Login / Signup

The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor-α inhibitor.

Taketo SuzukiTsutomu MizoshitaSatoshi TanidaNaomi SugimuraTakahito KatanoHirotada NishieHiromi Kataoka
Published in: JGH open : an open access journal of gastroenterology and hepatology (2019)
TAC is effective for remission induction in refractory UC patients with and without previous TNF-α inhibitor treatment. Maintenance medication after TAC therapy is an issue for the future, especially in UC cases with previous TNF-α inhibitor treatment failure.
Keyphrases
  • ulcerative colitis
  • rheumatoid arthritis
  • healthcare
  • disease activity
  • stem cells
  • mesenchymal stem cells
  • electronic health record